Watch this on-demand Webcast capturing expert presentations focused on the latest treatment strategies for patients with HER2+ breast cancer in the early and metastatic settings.
Download this short slideset of essential highlights from a live presentation on the latest developments in managing HER2-positive breast cancer.
Review the latest clinical data and expert guidance on management of HER2-positive early-stage breast cancer, including how to assess risk and plan (neo)adjuvant therapy; treat lower- vs higher-risk disease; and optimally manage adverse events associated with HER2-targeted therapy.
Get up to date on current and emerging HER2-targeted TKIs and antibody–drug conjugates for HER2-positive metastatic breast cancer across multiple lines of therapy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.